In COVID-19, particularly in regard to the emerging variants of concern, viral loads are higher and
viral replication is thought to be prolonged. Given that ivermectin has demonstrated a strong
dose-response relationship in terms of viral clearance, higher doses have not only been required,
but have demonstrated clinical efficacy. Below are hyperlinked references to numerous studies
demonstrating the wide safety profile of high dose ivermectin in COVID and other diseases
https://covid19criticalcare.com/wp-c...Ivermectin.pdf